National Healthcare CFO Summit
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe, it’s free!
  • Search
  • Menu Menu
International Hospital

Archive for category: E-News

E-News

Study reveals the microbiome’s role in regulating body temperature

, 28 February 2023/in E-News /by panglobal

What’s considered normal body temperature varies from person to person, yet overall, the average basal temperature of the human body has decreased since the 1860s for unknown reasons. A study points to the gut microbiome as a potential regulator of body temperature, both in health and during life-threatening infections.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/02/gut-bugs.jpg 1500 1500 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-02-28 09:35:052023-02-28 09:35:05Study reveals the microbiome’s role in regulating body temperature

Study finds hospitals without highest stroke care designation may miss strokes after TAVR

, 28 February 2023/in E-News /by panglobal

A Michigan Medicine study [1] suggests that hospitals without the highest stroke care designation may be missing strokes that occur after a common heart valve replacement procedure.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/02/stroke.jpg 551 1500 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-02-28 09:31:432023-02-28 09:31:43Study finds hospitals without highest stroke care designation may miss strokes after TAVR

Excessive screen time linked to higher risk of OCD in preteens

, 28 February 2023/in E-News /by panglobal

During the holidays, kids often spend more time on screens, leaving parents to wonder: Is it causing harm? Possibly.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/02/child_phone-scaled.jpg 2560 1758 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-02-28 09:26:392023-02-28 09:26:39Excessive screen time linked to higher risk of OCD in preteens

Pradel Research Award

, 28 February 2023/in E-News /by panglobal

Allen Institute’s Hongkui Zeng receives prestigious Pradel Research Award from National Academy of Sciences for pioneering work in neuroscience

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/02/Hongkui-Zeng-scaled.jpg 1707 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-02-28 09:01:462023-02-28 09:01:46Pradel Research Award

OHE Policy Innovation Prize

, 28 February 2023/in E-News /by panglobal

Prof. Aidan Hollis wins first £40,000 OHE Policy Innovation Prize to devise a globally applicable approach to fair pricing of medicines

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/02/Aidan_IPP-Prize-Winner.jpg 2560 1920 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-02-28 08:58:242023-02-28 08:58:24OHE Policy Innovation Prize

MDimune to collaborate with Hanyang University on projects selected through the 3rd BioDrone Award

, 28 February 2023/in E-News /by panglobal

MDimune, a Korean biotech company developing BioDrone platform technology based on cell-derived vesicles (CDVs), has received funding for two research projects focusing on next-generation drug delivery and novel therapeutics. The projects were selected through the 3rd BioDrone Award held in October 2022. For these projects, MDimune signed an MoU with Hanyang University to collaborate with […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/02/MDimmune.png 1434 1626 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-02-28 08:55:492023-02-28 08:55:49MDimune to collaborate with Hanyang University on projects selected through the 3rd BioDrone Award

Pfizer expands ‘An Accord for a Healthier World’ product offering to include full portfolio of medicines

, 28 February 2023/in E-News /by panglobal

Pfizer has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccines for which it has global rights on a not-for-profit basis to enable greater health for 1.2 billion people living in 45 lower-income countries.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/02/pfizer-accord-scaled.jpg 1707 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-02-28 08:43:032023-02-28 08:43:03Pfizer expands ‘An Accord for a Healthier World’ product offering to include full portfolio of medicines

Infection prevention and high-quality pulmonary care in operating theatres

, 22 February 2023/in E-News /by panglobal

Infection prevention and control are crucial for guaranteeing patient safety in operating theatres. When it comes to endoscopy, meticulous cleaning and high-level disinfection is needed to ensure clean and safe use of endoscopes, on subsequent patients.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/02/PENTAX-Medical-ONE-Pulmo-1.png 888 1330 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-02-22 09:00:572023-02-27 08:39:04Infection prevention and high-quality pulmonary care in operating theatres

Meet Fujifilm Europe at ECR 2023

, 16 February 2023/in E-News /by panglobal

Join Fujifilm Europe in Vienna, Austria, for new product launches, an MRI symposium, and a chance to meet our experts and learn how we can take on the healthcare challenge together.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/02/ecr-2023.jpg 516 780 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-02-16 18:12:472023-02-16 18:13:47Meet Fujifilm Europe at ECR 2023

Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Initiation of Phase II Study of naronapride in patients with gastroparesis

, 16 February 2023/in E-News /by panglobal

Randomized, double-blind, placebo-controlled study to evaluate efficacy of novel pan-GI prokinetic in patients with gastroparesis Renexxion Ireland Limited, a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet need in gastrointestinal (“GI”) disorders, is pleased to announce that the first patient has been treated in Europe with naronapride, a potential best-in-class […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/02/renexxion.png 204 400 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-02-16 10:02:012023-02-16 10:02:01Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Initiation of Phase II Study of naronapride in patients with gastroparesis
Page 2 of 200‹1234›»
  • National Healthcare CFO Summit
  • Marcusevans 36th national healthcare

Latest issue of International Hospital

January | February 2023

15 March 2023

Discover the latest genetic testing and Gene Therapy techniques at the SAUDI RARE DISEASE SUMMIT

15 March 2023

Healthcare provider in the Netherlands extends contract with Sectra and moves to cloud service

14 March 2023

Clario Launches Cloud-Based Image Viewer for Clinical Trials

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release

Hastelweg 250
5652 CN Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only